Antimicrobial activity of the Flo peptide produced in Scenedesmus acutus and Nannochloropsis oculata

Saraí Damaris Dávalos-Guzmán1, Fidel Martinez-Gutierrez1,2, Luzmila Martínez-González1

  • 1Facultad de Ciencias Químicas, Universidad Autónoma de San Luis Potosí, Av. Dr. Manuel Nava No.6, Zona Universitaria, San Luis Potosí, C.P. 78210, México.

Insights

Researchers engineered microalgae to produce the Flo peptide, a promising antimicrobial peptide from Moringa oleifera. This offers a novel strategy against antibiotic-resistant bacteria, leveraging biocompatible antimicrobial peptides.

Area of Science:

  • Biotechnology
  • Microbiology
  • Molecular Biology

Background:

  • Rising antibiotic resistance necessitates novel antimicrobial strategies.
  • Antimicrobial peptides (AMPs) offer a biocompatible alternative to conventional antibiotics.
  • Moringa oleifera contains AMPs with potential therapeutic applications.

Purpose of the Study:

  • To express the Flo peptide, an AMP from Moringa oleifera, in microalgae.
  • To evaluate the antimicrobial activity of the microalgae-expressed Flo peptide.
  • To assess the safety profile of the transplastomic microalgae.

Main Methods:

  • Flo peptide gene expression in Nannochloropsis oculata and Scenedesmus acutus chloroplasts.
  • Verification of transgene insertion via PCR and homoplasmy confirmation.
  • Quantification of Flo peptide using ELISA and antimicrobial activity assays against E. coli and K. pneumoniae.
  • Assessment of inflammatory cytokine secretion (IL-6, IL-10, TNF-α) and cytotoxicity.

Main Results:

  • Successful expression and verification of the Flo peptide in transplastomic microalgae.
  • Demonstrated antimicrobial activity of the Flo peptide against Gram-negative bacteria.
  • Initial assessment of inflammatory response and cytotoxicity of the engineered microalgae.

Conclusions:

  • Microalgae can be engineered as a sustainable platform for producing antimicrobial peptides.
  • The Flo peptide expressed in microalgae shows potential for combating antibiotic-resistant pathogens.
  • Further research is warranted to optimize production and assess in vivo efficacy.